Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-12-001428
Filing Date
2012-02-01
Accepted
2012-02-01 15:56:23
Documents
2
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 11340
2 LIMITED POWER OF ATTORNEY ex24khan.txt EX-24 4349
  Complete submission text file 0001179110-12-001428.txt   17093
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Khan Fazal R. (Reporting) CIK: 0001531959 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35409 | Film No.: 12562629